Anna Miti

Anna is a journalist at the Zimbabwe Broadcasting Corporation and also a media trainer and coordinator of media science cafes. She has been a broadcast journalist for the past fifteen years, covering most of the beats in the newsroom including current affairs and politics, arts, gender and even sports. She is a leader among health journalists in Zimbabwe, a member of the Federation of African Media Women in Zimbabwe and a member of the Editor’s Forum on HIV/AIDS.

Fellowship Focus
Anna pushed for HIV prevention options for young women and girls in Zimbabwe. Her work focused on awareness-raising, demand creation, media engagement and inclusion of young women and girls in research and rollout of interventions such as PrEP and microbicides. She created a network of civil society organizations and individuals focused on PrEP, microbicides and vaccines research advocacy, increased the quality and quantity of media coverage of HIV prevention and helped to bridge the gap between researchers and the communities for whom these interventions are developed.

In Their Own Words
My motivation is driven by the possibility that we can end AIDS by 2030, and that women all over the world can have prevention tools within their control, as currently they are sitting ducks for infection due to biological, social and cultural reasons.

My Work as a Fellow

• Blog: Anna started a blog to directly engage young women and those who develop and deliver programming for them to help raise issues of HIV prevention and young women, and to help find solutions to them.
• Blog post: In this HIV Vaccine Awareness Day piece, Anna challenges readers to join the search for an effective AIDS vaccine – to compliment the existing tools to help realize the end of AIDS.
• Fellowship summary report: “My Fellowship Year” is a report on Anna Miti’s advocacy for HIV prevention options for for young women and girls in Zimbabwe. It highlights her efforts on awareness-raising, demand creation, media engagement, and inclusion of young women and girls in research and rollout of interventions such as PrEP and microbicides.